维普期刊资源整合服务平台（V6.5）

64篇 您的检索式：作者名="Zochbauer"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Paclitaxel/cisplatin in advanced non-small-cell lung cancer (NSCLC)显示文摘	Pirker R Krajnik G Zochbauer S et a1		0，，08：	1
2	Aberrant methylation of multiple genes in the upper aerodigestive tract epithelium of heavysmokers显示文摘	Zochbauer Muller S Lain S Toyooka S	2003	Int J Cancer2003，107，4：	1
3	Paclitaxel/cisplatin in advanced non-small cell lung cancer (NSCLC)显示文摘	Krajnik G Zochbauer S	1995	Ann Oncol1995，6，8：	1
4	Paclitaxel/cisplatin in advanced non-small cell lung cancer显示文摘	Pirker R Krajnik G Zochbauer S	1995	Ann Oncol1995，6，：	1
5	Aberrant promoter methylation of multiple genes in non-small cell lung cancers显示文摘	Zochbauer Muller S Fong KM Virmani AK	2001	Cancer Res2001，61，：	1
6	5' CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer显示文摘	ZOCHBAUER MULLER S FONG K M MAITRA A	2001	Cancer Res2001，61，9：	1
7	Aberrant promoter methylation of multiple genes innonsmall cell lung cancers 显示文摘	ZOCHBAUER M S'FUNG K M VIRMANI A K etal	2001	Cancer Res2001，61，：	1
8	5′CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer显示文摘	Zochbauer Muller S Fong KM Maitra A	2001	Cancer Res2001，，9：	1
9	Epigenetie inactivationOf RASSF1A in lung and breast cancer and malignant phenotype suppression显示文摘	Burbee DG Forgaes E Zochbauer MS	2001	Natl Cancer Inst2001，93，：	1
10	Epigenetic inactivation of RASSFIA in lung and breast cancer and malignant phenotype suppression 显示文摘	Burbee DG Forgacs E Zochbauer - Muller S	2001	J Natl Cancer lnst2001，93，9：	1
11	5'-CpG island methylation of the FHIT gene is correlated with loss of gene expression in lung and breast cancer显示文摘	Zochbauer MS Fong KM Maitra A	2001	Cancer Res2001，61，9：	1
12	Aberrant DNA methylation in lung cancer: biological and clinical implications显示文摘	Zochbauer Muller S Minna J D Gazdar A F	2002	Oncologist2002，7，5：	1
13	Paclitaxel/cispiatin in advanced non-small-cell lung cancer(NSCLC)显示文摘	Pirker R Krajnik G Zochbauer S	1995	Ann Oncol1995，6，8：	1
14	Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression显示文摘	Burbee DG Forgacs E Zochbauer Muller S	2001	J Natl Cancer Inst2001，93，9：	1
15	Aberrant DNA methylation in lung cancer: biological and clinical implications 显示文摘	Zochbauer Muller S Minna J D Gazdar A F	2002	Oncologist2002，7，5：	1
16	Paclitaxel/cisplatin in advanced non-small-cell lung cancer (NSCLC)显示文摘	PIRKER R KRAJNIK G ZOCHBAUER S	1995	Ann Oncol1995，6，8：	1
17	Epigenetic inactiva- tion of RASSF1A in lung and breast cancers and malignant ph- enotype suppression显示文摘	Burbee DG Forgacs E Zochbauer MS	2001	Nat Cancer Inst2001，93，9：	1
18	Fragile histidine triad (FHIT) gene abnormalities in lung cancer 显示文摘	Zochbauer - Muller S Wistuba II Minna JvD Gazdar A F	2000	Clin Lung Cancer2000，2，：	1
19	Aberrant promoter methylation of multiple genes in non-small cell lung cancers显示文摘	Zochbauer Muller S Fong KM Virmani A	2001	Cancer Res2001，61，1：	1
20	Aberrant promoter methylation ofmultiple genes in non-small cell lung cancers 显示文摘	Zochbauer MS Fong KM Virmani AK	2001	Cancer Res2001，61，1：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示